Vera Therapeutics, Inc. (VERA)
36.80
+0.20
(+0.56%)
USD |
NASDAQ |
May 07, 09:45
Vera Therapeutics Cash from Investing (Quarterly) : 80.66M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | -36.46M |
| Syndax Pharmaceuticals, Inc. | 38.39M |
| United Therapeutics Corp. | 743.70M |
| Cytokinetics, Inc. | 145.49M |
| Insmed, Inc. | 389.41M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -69.99M |
| Cash from Financing (Quarterly) | 286.28M |
| Free Cash Flow | -241.73M |
| Free Cash Flow Per Share (Quarterly) | -1.073 |
| Free Cash Flow to Equity (Quarterly) | -70.19M |
| Free Cash Flow to Firm (Quarterly) | -68.19M |
| Free Cash Flow Yield | -10.24% |